9
Participants
Start Date
May 18, 2017
Primary Completion Date
September 10, 2019
Study Completion Date
September 10, 2019
Ibrutinib
"Ibrutinib is a type of drug called a kinase inhibitor. Kinases are proteins inside cells that help cells live and grow. Ibrutinib blocks a specific kinase protein in our bodies. This protein is thought to be very important in helping blood cancer cells live and grow. By blocking this kinase protein, ibrutinib stops cancer cells from growing."
Icahn School of Medicine at Mount Sinai, New York
Collaborators (1)
Pharmacyclics LLC.
INDUSTRY
Icahn School of Medicine at Mount Sinai
OTHER